Skip to content

Cardiac Rehabilitation after Myocardial Infarction

Efficacy of Cardiac Rehabilitation after Acute Myocardial Infarction: Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9nyx8hb
Enrollment
Unknown
Registered
2022-11-22
Start date
2022-11-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Interventions

This is a two-arm, single-blind, randomized controlled clinical trial. The Experimental group with 12 participants of both sexes, after 8 hours of clinical stability in the ICU, will perform the initi

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Clinical diagnosis of acute myocardial infarction (ECG and cardiac enzymes) with or without ST elevation and uncomplicated (Killip I or II); successfully submitted to percutaneous coronary intervention (PCI) (Flow Timi 3 or 2); age group between 18 and 70 years; both sexes; classified as low risk (Absence of ventricular dysrhythmias, absence of clinical depression and absence of ischemic signs after the procedure)

Exclusion criteria

Exclusion criteria: Osteomioarticular alterations that prevent the performance of exercises; signs and symptoms of ischemia or cardiac decompensation; atrial or ventricular arrhythmias; EF (Ejection Fraction) < 50%; diagnosed chronic lung diseases

Design outcomes

Primary

MeasureTime frame
Cardiorespiratory fitness measured by measuring VO2 by cardiopulmonary test 30 days after hospital discharge;;Ventricular remodeling evaluated through a semi-quantitative scale using cardiac resonance performed before the intervention, 30 days and 3 months after hospital discharge.;Cardiac autonomic function measured through heart rate variability, before the intervention and 30 days after hospital discharge.

Secondary

MeasureTime frame
Exercise dose provided during rehabilitation measured from the time, intensity and frequency of sessions provided during in-hospital cardiac rehabilitation.;Submaximal functional capacity from the 30-second sit-up test result;Cardiovascular safety measured from the rate of adverse events per offered rehabilitation sessions.

Countries

Brazil

Contacts

Public ContactCaroline Schon

Universidade Federal do Rio Grande do Norte

caroline.schon@ebserh.gov.br+55 (84) 3215-4270

Outcome results

None listed

Source: REBEC (via WHO ICTRP)